Group 1 - Company achieved total operating revenue of 1,030,010.44 million yuan in 2024, a year-on-year decrease of 9.73% [2] - Net profit attributable to shareholders of the listed company was 126,186.95 million yuan, down 36.08% year-on-year [2] - The decline in revenue is primarily due to the impact of domestic equipment update policy implementation, leading to an overall contraction in the industry [2] Group 2 - Company has increased R&D investment, with no significant changes in core competitiveness [2][4] - Company has applied for a total of 11,502 intellectual property rights and has obtained 5,882 [2][4] - There were no violations found in the use of raised funds, and there were no significant changes in the holdings of controlling shareholders and executives during the reporting period [2]
每周股票复盘:联影医疗(688271)2024年营收与净利润双双下滑